This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
CADTH. Abuse and misuse potential of drugs for attention deficit/hyperactivity disorder: a review of the clinical evidence. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013
No conclusions can be drawn regarding the abuse potential of atomoxetine due to the limited data available. Misuse of methylphenidate and amphetamine-based ADHD drugs was found in adolescent and young adult population, particularly among undergraduate university students. Misuse of ADHD stimulants also occurred in non-institutionalized adults. The prevalence of stimulant misuse among studies ranged from 5% to 35% in adults and from 5% to 12% in adolescents. There was evidence for potential diversion of stimulant ADHD medication from individuals with prescriptions to individuals without prescriptions.
Subject indexing assigned by CRD
Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Risk-Taking; Self Medication; Substance-Related Disorders
Country of organisation
An English language summary is available.
Address for correspondence
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: firstname.lastname@example.org
Date abstract record published